background
vitamin
may
import
immun
function
studi
date
shown
inconsist
associ
vitamin
infect
respiratori
virus
purpos
studi
determin
serum
oh
associ
laboratoryconfirm
viral
respiratori
tract
infect
rti
children
method
serum
oh
level
measur
baselin
children
canadian
hutterit
commun
follow
prospect
respiratori
viru
season
nasopharyng
specimen
obtain
symptom
develop
infect
confirm
use
polymeras
chain
reaction
associ
serum
oh
time
laboratoryconfirm
viral
rti
evalu
use
cox
proport
hazard
model
result
seven
hundr
fortythre
children
age
year
follow
decemb
june
median
serum
oh
level
nmoll
interquartil
rang
total
particip
develop
least
laboratoryconfirm
viral
rti
younger
age
lower
serum
oh
level
associ
increas
risk
viral
rti
serum
oh
level
nmoll
increas
risk
viral
rti
hazard
ratio
hr
confid
interv
ci
p
level
nmoll
increas
risk
hr
ci
p
conclus
lower
serum
oh
level
associ
increas
risk
laboratoryconfirm
viral
rti
children
canadian
hutterit
commun
intervent
studi
evalu
role
vitamin
supplement
reduc
burden
viral
rti
warrant
viral
upper
respiratori
tract
infect
rti
common
worldwid
despit
perceiv
benign
natur
burden
diseas
signific
term
morbid
econom
loss
viral
respiratori
infect
may
also
associ
mortal
certain
patient
popul
unfortun
treatment
remain
unsatisfactori
often
focus
symptom
relief
result
prevent
remain
key
strategi
reduc
burden
infect
increas
interest
role
vitamin
respiratori
infect
vitamin
shown
import
role
innat
adapt
immun
respons
particular
vitamin
link
innat
immun
respons
lung
epitheli
cell
addit
antimicrobi
peptid
induc
vitamin
may
antivir
effect
activ
shown
herp
simplex
viru
type
adenoviru
human
immunodefici
viru
hiv
vaccinia
viru
sever
observ
studi
evalu
role
serum
oh
concentr
respiratori
tract
infect
howev
studi
import
limit
includ
short
followup
period
small
sampl
size
casecontrol
design
crosssect
design
retrospect
ascertain
symptom
failur
obtain
laboratori
confirm
selfreport
ill
studi
adult
shown
associ
lower
vitamin
level
increas
respiratori
infect
selfreport
absenc
work
due
respiratori
symptom
howev
pediatr
studi
focus
predominantli
lower
rti
chest
radiographyconfirm
pneumonia
bronchiol
relationship
serum
oh
concentr
upper
rti
children
evalu
purpos
studi
determin
serum
oh
level
associ
subsequ
risk
laboratoryconfirm
viral
upper
rti
children
adolesc
conduct
prospect
cohort
studi
children
adolesc
particip
cluster
random
control
trial
evalu
effect
influenza
vaccin
children
viral
infect
rate
hutterit
commun
result
publish
elsewher
hutterit
commun
coloni
rural
selfgovern
selfsuffici
communalliv
group
anabaptist
rct
children
underli
chronic
medic
condit
year
age
n
coloni
randomli
assign
coloni
receiv
either
inactiv
season
influenza
vaccin
children
underli
condit
n
children
n
follow
random
particip
follow
regularli
twiceweekli
assess
research
nurs
influenza
season
defin
start
date
laboratoryconfirm
influenza
case
consecut
week
stop
date
laboratoryconfirm
influenza
case
consecut
week
period
decemb
june
covari
interest
age
sex
presenc
asthma
presenc
underli
condit
influenza
vaccin
oh
level
nmoll
serum
oh
level
collect
children
baselin
unless
bloodwork
refus
serum
venou
blood
frozen
batch
analysi
perform
accord
manufactur
instruct
use
diasorin
liaison
chemiluminesc
assay
serum
oh
level
taken
octob
april
taken
octob
decemb
n
primari
outcom
laboratoryconfirm
viral
infect
defin
posit
nasopharyng
swab
polymeras
chain
reaction
pcr
result
copan
flock
nasopharyng
swab
copan
italia
brescia
itali
collect
univers
transport
medium
copan
italia
follow
symptom
present
fever
cough
nasal
congest
sore
throat
headach
sinu
problem
muscl
ach
fatigu
ear
ach
infect
chill
specimen
first
test
influenza
includ
b
use
center
diseas
control
prevent
human
influenza
viru
realtim
revers
transcript
pcr
detect
character
panel
neg
specimen
test
influenza
b
coronaviru
enteroviru
includ
rhinoviru
parainfluenza
respiratori
syncyti
viru
rsv
b
human
metapneumoviru
xtag
respiratori
viru
panel
multiplex
pcr
luminex
austin
texa
surviv
analysi
use
assess
relationship
time
laboratoryconfirm
viral
respiratori
infect
serum
oh
level
univari
analys
conduct
obtain
unadjust
hazard
ratio
hr
signific
determin
use
logrank
test
vitamin
level
analyz
continu
variabl
logtransform
correct
posit
skew
dichotom
base
american
academi
pediatr
aap
nmoll
canadian
paediatr
societi
cp
nmoll
recommend
age
also
analyz
continu
variabl
categor
group
year
year
year
cox
proport
hazard
model
use
estim
adjust
hazard
ratio
ahr
model
adjust
cluster
coloni
level
variabl
p
valu
consid
inclus
multivari
model
final
model
determin
use
stepwis
backward
elimin
method
decid
priori
adjust
final
model
age
sex
proport
hazard
assumpt
evalu
use
residu
test
graphic
use
residu
loglog
curv
examin
variabl
time
depend
overal
model
fit
assess
use
coxsnel
residu
devianc
residu
plot
recurr
event
analysi
conduct
examin
relationship
oh
rate
occurr
respiratori
tract
infect
adjust
biolog
plausibl
covari
specifi
count
process
model
use
treat
recurr
event
ident
model
adjust
cluster
coloni
level
estim
present
confid
interv
ci
p
valu
consid
statist
signific
analys
conduct
use
stata
statist
softwar
releas
statacorp
colleg
station
texa
baselin
characterist
summar
tabl
children
age
year
rct
random
influenza
hepat
vaccin
children
coloni
serum
oh
level
includ
studi
appreci
differ
particip
serum
oh
level
without
mean
age
univari
analys
age
serum
oh
level
associ
rti
tabl
multivari
analysi
account
cluster
coloni
level
serum
oh
level
independ
associ
viral
rti
tabl
everi
increas
log
serum
oh
level
correspond
increas
serum
oh
level
hazard
develop
respiratori
tract
infect
decreas
ahr
ci
p
level
dichotom
base
aap
cp
recommend
level
nmoll
ahr
ci
p
nmoll
ahr
ci
p
associ
increas
risk
infect
figur
age
also
independ
associ
viral
rti
multivari
analysi
children
age
year
highest
risk
rti
compar
age
year
ahr
ci
p
year
ahr
ci
p
interact
found
serum
oh
level
either
age
sex
multipl
viral
rti
event
taken
account
age
log
serum
oh
level
associ
increas
rate
occurr
respiratori
tract
infect
tabl
serum
oh
level
import
predictor
continu
variabl
ahr
ci
p
dichotom
base
level
nmoll
ahr
ci
p
nmoll
ahr
ci
p
younger
age
confer
increas
risk
viral
rti
hazard
ratio
everi
decreas
age
ahr
ci
p
found
statist
signific
associ
serum
oh
laboratoryconfirm
viral
rti
children
hutterit
commun
canada
lower
serum
oh
level
associ
increas
risk
rti
adjust
age
sex
younger
age
also
associ
increas
risk
studi
provid
novel
inform
effect
vitamin
statu
laboratoryconfirm
viral
upper
rti
children
adolesc
previou
studi
shown
children
ricket
increas
risk
lower
respiratori
tract
diseas
pneumonia
recent
sever
observ
studi
shown
associ
low
serum
oh
level
risk
lower
respiratori
tract
infect
children
india
bangladesh
turkey
studi
extend
result
suggest
vitamin
statu
may
also
import
suscept
viral
upper
rti
children
adolesc
find
consist
adult
literatur
confirm
intervent
trial
find
may
import
public
health
implic
given
frequenc
viral
upper
rti
associ
morbid
preval
low
vitamin
level
found
serum
oh
level
import
predictor
rti
continu
variabl
per
chang
log
oh
also
dichotom
level
nmoll
aap
recommend
level
nmoll
cp
recommend
therefor
although
maintain
level
nmoll
import
prevent
ricket
higher
level
may
need
prevent
viral
rti
suggest
recent
studi
involv
healthi
adult
serum
oh
concentr
ngml
approxim
nmoll
associ
reduc
incid
acut
viral
respiratori
tract
infect
studi
children
need
determin
optim
level
requir
immun
function
canadian
studi
fail
show
associ
vitamin
statu
risk
hospit
acut
lower
respiratori
infect
children
year
age
although
differ
vitamin
level
found
studi
higher
proport
particip
acut
lower
respiratori
infect
found
vitamin
receptor
polymorph
associ
reduc
receptor
express
one
studi
find
associ
serum
oh
level
upper
rti
children
year
age
may
relat
differ
popul
urban
vs
rural
genet
differ
vitamin
receptor
polymorph
studi
design
serum
oh
measur
outcom
upper
vs
lower
rti
role
serum
oh
level
individu
respiratori
virus
studi
postul
lower
vitamin
level
may
explain
season
variat
influenza
case
rsv
infect
studi
shown
rsvinfect
human
airway
epitheli
cell
vitamin
induc
inhibitor
airway
epithelium
decreas
rsv
induct
inflammatori
gene
although
unabl
look
serum
oh
level
risk
individu
respiratori
virus
area
warrant
research
serum
oh
level
may
impact
virus
differ
studi
sever
limit
first
obtain
vitamin
measur
particip
therefor
exact
level
around
time
rti
howev
serum
oh
measur
taken
around
time
octob
novemb
reflect
vitamin
statu
start
respiratori
infect
season
prior
develop
viral
rti
believ
estim
appropri
estim
taken
time
ill
impact
acut
viral
ill
serum
oh
level
studi
level
also
taken
time
level
tend
peak
northern
hemispher
therefor
unlik
vitamin
level
would
rebound
earli
spring
appreci
impact
infect
occur
later
followup
period
addit
particip
serum
oh
level
obtain
followup
period
start
sensit
analysi
remov
estim
also
affect
result
third
limit
data
collect
sourc
vitamin
intak
individu
particip
howev
data
demonstr
vitamin
supplement
use
fortifi
food
part
routin
practic
hutterit
commun
therefor
feel
would
affect
analysi
final
studi
conduct
hutterit
children
adolesc
may
generaliz
popul
studi
evalu
pediatr
popul
warrant
found
children
adolesc
lower
vitamin
level
increas
risk
laboratoryconfirm
viral
upper
rti
current
recommend
regard
target
serum
oh
level
may
low
prevent
viral
upper
rti
studi
provid
evid
support
futur
intervent
trial
examin
efficaci
vitamin
supplement
viral
rti
children
adolesc
